Alnylam kicks off its third round in mRNA delivery battle
Monitoring litigations in the therapeutic mRNA field SOPHIA ANTIPOLIS, France – June 06, 2023 │ With the COVID-19 crisis, mRNA technologies have become key for numerous players. After the success of mRNA vaccine and the related hype, players are looking to settle their activity and strengthen their position. With this new phase comes litigations. Moderna[…]